A bone tumor is an abnormal growth of cells within a bone. A bone tumor may be cancerous (malignant) or noncancerous (benign).
Tumor - bone; Bone cancer; Primary bone tumor; Secondary bone tumor; Bone tumor - benign
The cause of bone tumors is unknown. They often occur in areas of the bone that grow rapidly. Possible causes include:
In most cases, no specific cause is found.
Osteochondromas are the most common noncancerous (benign) bone tumors. They occur most often in young people between the ages of 10 and 20.
Cancers that start in the bones are called primary bone tumors. Bone cancers that start in another part of the body (such as the breast, lungs, or colon) are called secondary or metastatic bone tumors. They behave very differently from primary bone tumors.
Cancerous primary bone tumors include:
Cancers that most often spread to the bone are cancers of the:
These forms of cancer usually affect older people.
Bone cancer is more common in people who have a family history of cancers.
Symptoms of bone tumor may include any of the following:
Some benign tumors have no symptoms.
Some benign bone tumors go away on their own and do not need treatment. Your provider will closely monitor you. You will likely need regular imaging tests, such as x-rays, to see if the tumor shrinks or grows.
Surgery may be needed to remove the tumor in some cases.
Treatment for cancerous bone tumors that have spread from other parts of the body depends on where the cancer started. Radiation therapy may be given to prevent fractures or to relieve pain. Chemotherapy may be used to prevent fractures or the need for surgery or radiation.
Tumors that start in the bone are rare. After biopsy, a combination of chemotherapy and surgery is usually necessary. Radiation therapy may be needed before or after surgery.
Mark Bilsky is a Neurosurgery expert in New York, New York. Bilsky has been practicing medicine for over 35 years and is rated as an Elite expert by MediFind in the treatment of Bone Tumor. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Chordoma, Bone Tumor, Spinal Tumor, Vertebroplasty, and Laminectomy. Bilsky is currently accepting new patients.
Laurence Rhines is a Neurosurgery specialist and a Surgical Oncologist in Houston, Texas. Rhines has been practicing medicine for over 30 years and is rated as an Elite expert by MediFind in the treatment of Bone Tumor. He is also highly rated in 7 other conditions, according to our data. His top areas of expertise are Chordoma, Bone Tumor, Spinal Tumor, Vertebroplasty, and Laminectomy. Rhines is currently accepting new patients.
Shaan Raza is a Neurosurgery expert in Houston, Texas. Raza has been practicing medicine for over 17 years and is rated as an Elite expert by MediFind in the treatment of Bone Tumor. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Bone Tumor, Meningioma, Olfactory Neuroblastoma, Endoscopy, and Awake Craniotomy. Raza is currently accepting new patients.
You can ease the stress of illness by joining a cancer support group. Sharing with others who have common experiences and problems can help you not feel alone.
How well you do depends on the type of bone tumor.
Outcome is usually good in people with noncancerous (benign) tumors. But some benign bone tumors can turn into cancer.
People with cancerous bone tumors that have not spread may be cured. The cure rate depends on the type of cancer, location, size, and other factors. Talk to your provider about your particular cancer.
Problems that may result from the tumor or treatment include:
Call your provider if you have symptoms of a bone tumor.
Summary: The objectives of this clinical observational study is to evaluate the safety and efficacy (performance) of the Neo Pedicle Screw System™ and the Neo Cage System™ interbody fusion device. To demonstrate non-inferiority of safety and function to an historical control from the published medical literature on competitive devices.
Summary: MEKTOVI (binimetinib) is an oral, highly selective reversible inhibitor of mitogen-activated extracellular signal regulated kinase 1 (MEK1) and MEK2. The biological activity of binimetinib that has been evaluated bith in vitro and in vivo in a wide variety of tumor types In this Phase II, the drug will be used to treat pediatric patients diagnosed with recurrent Adamantinomatous Craniopharyngioma ...
Published Date: January 25, 2022
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Heck RK, Toy PC. Malignant tumors of bone. In: Azar FM, Beaty JH, eds. Campbell's Operative Orthopaedics. 14th ed. Philadelphia, PA: Elsevier; 2021:chap 27.
National Comprehensive Cancer Network website. NCCN clinical practice guidelines in oncology (NCCN guidelines): Bone cancer. Version 2.2022. www.nccn.org/professionals/physician_gls/pdf/bone.pdf. Updated October 8, 2021. Accessed June 9, 2022.
Reith JD. Bone and joints. In: Goldblum JR, Lamps LW, McKenney JK, Myers JL, eds. Rosai and Ackerman's Surgical Pathology. 11th ed. Philadelphia, PA: Elsevier; 2018:chap 40.
Toy PC, Heck RK Benign bone tumors and nonneoplastic conditions simulating bone tumors. In: Azar FM, Beaty JH, eds. Campbell's Operative Orthopaedics. 14th ed. Philadelphia, PA: Elsevier; 2021:chap 25.